Healthtech platform SwipeRx raises US$27m
Add BT as a preferred source
Claudia Chong
SWIPERX, formerly known as mClinica Pharmacy Solutions, has raised US$27 million in equity and borrowings.
The Series B round was led by Indonesia’s MDI Ventures, with participation from the Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures, Susquehanna International Group and existing investors.
The latest funds will be used to further accelerate their growth across South-east Asia with a focus on Indonesia.
SwipeRx’s digital platform connects pharmacies in South-east Asia, where many operate as largely fragmented mom-and-pop shops that have yet to digitise.
Its network of pharmacies have access to online education and drug information, and are provided with a forum to communicate with each other.
SwipeRx connects its members in a digital purchasing network so small pharmacies can benefit from the cost-savings of bulk purchases. Financing options are provided to them as well.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
The Singapore-based startup said more than 235,000 pharmacy professionals and 45,000 pharmacies have registered on its platform. It works with multinational companies, governments and non-governmental organisations within the entire pharmaceutical ecosystem.
SwipeRx operates in Indonesia, the Philippines, Vietnam, Malaysia, Thailand and Cambodia. It is planning to expand its specialised healthcare logistics to fulfil business-to-business commerce, and recruit talent across the region. The company said it has over 400 employees.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
